1. Home
  2. ROIV vs LSCC Comparison

ROIV vs LSCC Comparison

Compare ROIV & LSCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$22.56

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Logo Lattice Semiconductor Corporation

LSCC

Lattice Semiconductor Corporation

HOLD

Current Price

$75.13

Market Cap

9.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
LSCC
Founded
2014
1983
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
14.1B
9.6B
IPO Year
N/A
1989

Fundamental Metrics

Financial Performance
Metric
ROIV
LSCC
Price
$22.56
$75.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
11
Target Price
$24.31
$76.18
AVG Volume (30 Days)
8.2M
1.9M
Earning Date
02-09-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.20
Revenue
$20,329,000.00
$494,889,000.00
Revenue This Year
N/A
$4.23
Revenue Next Year
$376.94
$21.23
P/E Ratio
N/A
$379.71
Revenue Growth
N/A
N/A
52 Week Low
$8.73
$34.69
52 Week High
$23.47
$81.23

Technical Indicators

Market Signals
Indicator
ROIV
LSCC
Relative Strength Index (RSI) 61.61 55.89
Support Level $21.60 $71.27
Resistance Level $23.47 $79.97
Average True Range (ATR) 0.88 3.31
MACD 0.06 -0.30
Stochastic Oscillator 69.09 50.17

Price Performance

Historical Comparison
ROIV
LSCC

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

Share on Social Networks: